Drug Profile
Atorvastatin/candesartan cilexetil
Alternative Names: AG 1502Latest Information Update: 25 Aug 2023
Price :
$50
*
At a glance
- Originator Ahn-Gook Pharmaceutical
- Class Antihyperlipidaemics; Antihypertensives; Small molecules
- Mechanism of Action Angiotensin type 1 receptor antagonists; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hyperlipidaemia; Hypertension
Most Recent Events
- 25 Aug 2023 Discontinued - Preclinical for Hyperlipidaemia in South Korea (PO)
- 25 Aug 2023 Discontinued - Preclinical for Hypertension in South Korea (PO)
- 28 Jan 2020 No recent reports of development identified for preclinical development in Hyperlipidaemia in South Korea (PO)